[1] |
Otero-Abad B, Torgerson PR. A systematic review of the epidemiology of echinococcosis in domestic and wild animals[J]. PLoS Negl Trop Dis, 2013,7(6):e2249.
doi: 10.1371/journal.pntd.0002249
|
[2] |
Siles-Lucas M, Casulli A, Cirilli R, et al. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets[J]. PLoS Negl Trop Dis, 2018,12(4):e0006422.
doi: 10.1371/journal.pntd.0006422
|
[3] |
Vuitton DA, Azizi A, Richou C, et al. Current interventional strategy for the treatment of hepatic alveolar echinococcosis[J]. Expert Rev Anti Infect Ther, 2016,14(12):1179-1194.
doi: 10.1080/14787210.2016.1240030
|
[4] |
Lanaya H, Natarajan A, Komposch K, et al. EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation[J]. Nat Cell Biol, 2014,16(10):972-977.
doi: 10.1038/ncb3031
|
[5] |
Miyamoto Y, Suyama K, Baba H. Recent advances in targeting the EGFR signaling pathway for the treatment of metastatic colorectal cancer[J]. Int J Mol Sci, 2017,18(4):E752.
|
[6] |
Tomas A, Futter CE, Eden ER. EGF receptor trafficking: consequences for signaling and cancer[J]. Trends Cell Biol, 2014,24(1):26-34.
doi: 10.1016/j.tcb.2013.11.002
|
[7] |
Liu XD, Tian S, Liu M, et al. Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF-κB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling[J]. Int J Mol Med, 2016,38(4):1250-1256.
doi: 10.3892/ijmm.2016.2700
|
[8] |
Spiliotis M, Lechner S, Tappe D, et al. Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles[J]. Int J Parasitol, 2008,38(8/9):1025-1039.
doi: 10.1016/j.ijpara.2007.11.002
|
[9] |
Spiliotis M, Brehm K. Axenic in vitro cultivation of Echinococcus multilocularis metacestode vesicles and the generation of primary cell cultures[J]. Methods Mol Biol, 2009,470:245-262.
doi: 10.1007/978-1-59745-204-5_17
pmid: 19089387
|
[10] |
Anborgh PH, Mutrie JC, Tuck AB, et al. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment[J]. J Cell Mol Med, 2010,14(8):2037-2044.
doi: 10.1111/j.1582-4934.2010.01115.x
pmid: 20597997
|
[11] |
Weber GF, Lett GS, Haubein NC. Osteopontin is a marker for cancer aggressiveness and patient survival[J]. Br J Cancer, 2010,103(6):861-869.
doi: 10.1038/sj.bjc.6605834
|
[12] |
Lee SH, Park JW, Woo SH, et al. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice[J]. Oncotarget, 2016,7(52):87219-87231.
doi: 10.18632/oncotarget.v7i52
|
[13] |
Matušan-Ilijaš K, Damante G, Fabbro D, et al. EGFR expression is linked to osteopontin and NF-κB signaling in clear cell renal cell carcinoma[J]. Clin Trans Oncol, 2013,15(1):65-71.
doi: 10.1007/s12094-012-0889-9
|
[14] |
Lamour V, Henry A, Kroonen J, et al. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo[J]. Int J Cancer, 2015,137(5):1047-1057.
doi: 10.1002/ijc.v137.5
|
[15] |
Peng XY, Li JH, Wu XW, et al. Detection of osteopontin in the pericyst of human hepatic Echinococcus granulosus[J]. Acta Trop, 2006,100(3):163-171.
doi: 10.1016/j.actatropica.2006.08.013
|
[16] |
Zhang L, Zhang SJ, Cao YW, et al. The correlation between osteopontin and metastasis of hepatic Echinococcus multilocularis infection[J]. Chin J Parasitol Parasit Dis, 2011,29(1):33-36. (in Chinese)
|
|
( 张龙, 张示杰, 曹玉文, 等. 骨桥蛋白与肝泡型棘球蚴转移的相关性研究[J]. 中国寄生虫学与寄生虫病杂志, 2011,29(1):33-36.)
|
[17] |
Simmerman E, Qin X, Yu JC, et al. Cannabinoids as a potential new and novel treatment for melanoma: a pilot study in a murine model[J]. J Surg Res, 2019,235:210-215.
doi: 10.1016/j.jss.2018.08.055
pmid: WOS:000456777000027
|
[18] |
Hemer S, Konrad C, Spiliotis M, et al. Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development[J]. BMC Biol, 2014,12:5.
doi: 10.1186/1741-7007-12-5
|
[19] |
Cheng Z, Liu F, Li X, et al. EGF-mediated EGFR/ERK signaling pathway promotes germinative cell proliferation in Echinococcus multilocularis that contributes to larval growth and development[J]. PLoS Negl Trop Dis, 2017,11(2):e0005418.
doi: 10.1371/journal.pntd.0005418
|
[20] |
Förster S, Koziol U, Schäfer T, et al. The role of fibroblast growth factor signalling in Echinococcus multilocularis development and host-parasite interaction[J]. PLoS Negl Trop Dis, 2019,13(3):e0006959.
doi: 10.1371/journal.pntd.0006959
|
[21] |
Roskoski R Jr. The ErbB/HER family of protein-tyrosine kinases and cancer[J]. Pharmacol Res, 2014,79:34-74.
doi: 10.1016/j.phrs.2013.11.002
|
[22] |
Weihua WH, Tsan R, Huang WC, et al. Survival of cancer cells is maintained by EGFR independent of its kinase activity[J]. Cancer Cell, 2008,13(5):385-393.
doi: 10.1016/j.ccr.2008.03.015
pmid: 18455122
|
[23] |
Cheng Z, Xu ZJ, Tian HM, et al. In vitro and in vivo efficacies of inhibitors of the EGFR/MEK/ERK signaling in the treatment of alveolar echinococcosis[J]. Antimicrob Agents Chemother, 2020,64(8):e00341-20.
|
[24] |
Wang M, Han J, Marcar L, et al. Radiation resistance in KRAS-mutated lung cancer is enabled by stem-like properties mediated by an osteopontin-EGFR pathway[J]. Cancer Res, 2017,77(8):2018-2028.
doi: 10.1158/0008-5472.CAN-16-0808
|
[25] |
Li T, Wu XW, Zhang YG, et al. Effects of anti-osteopontin antibody on expression of MMP-2 and TGF-β1 in hepatic alveolar hydatid tissue of gerbil[J]. Chin J Parasitol Parasit Dis, 2013,31(6):450-453. (in Chinese)
|
|
( 荔童, 吴向未, 张永国, 等. 抗骨桥蛋白抗体对沙鼠肝多房棘球蚴组织中的基质金属蛋白酶2和转化生长因子β1的影响[J]. 中国寄生虫学与寄生虫病杂志, 2013,31(6):450-453.)
|
[26] |
Pietras A, Katz AM, Ekström EJ, et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth[J]. Cell Stem Cell, 2014,14(3):357-369.
doi: 10.1016/j.stem.2014.01.005
|
[27] |
Nardo AD, Grün NG, Zeyda M, et al. Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma[J]. Liver Int, 2020,40(7):1620-1633.
doi: 10.1111/liv.v40.7
|
[28] |
Wang HH, Guo DH, Li JJ, et al. Increased expression of osteopontin indicates poor prognosis in hepatocellular carcinoma[J]. Int J Clin Exp Pathol, 2018,11(12):5916-5922.
|
[29] |
Sun TT, Tang YR, Sun DW, et al. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis[J]. Oncotargets Ther, 2018,11:8925-8935.
doi: 10.2147/OTT
|
[30] |
Cheng YG, Wen G, Sun Y, et al. Osteopontin promotes colorectal cancer cell invasion and the stem cell-like properties through the PI3K-AKT-GSK/3β-β/catenin pathway[J]. Med Sci Monit, 2019,25:3014-3025.
doi: 10.12659/MSM.913185
|
[31] |
Tsai W, Tsai W, Lee H, et al. Association between osteopontin and EGFR expression with clinicopathological parameters in hepatocellular carcinoma[J]. Chin J Physiol, 2012,55(6):412-420.
doi: 10.4077/CJP.2012.BAA082
|